Cargando…

Early intervention of plasma exchange combined with intensive immunosuppressive treatment for anti-MDA-5 antibody–positive rapidly progressive interstitial pneumonia: Two case reports

BACKGROUND: Anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab) has to be reported to often cause rapidly progressive interstitial lung disease (RP-ILD) especially in East Asian countries. Even with the recommended rapid administration of immunosuppressive agents with high-dose c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishiwari, Mayuko, Togashi, Yuki, Takoi, Hiroyuki, Kikuchi, Ryota, Kawagoe, Junichiro, Toriyama, Kazutoshi, Tanaka, Akane, Nagotomo, Yoko, Kinoshita, Hayato, Kono, Yuta, Abe, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349010/ https://www.ncbi.nlm.nih.gov/pubmed/34401300 http://dx.doi.org/10.1016/j.rmcr.2021.101464

Ejemplares similares

Impact of sarcopenia on chemotherapy‐triggered exacerbation of interstitial lung disease in patients with non‐small cell lung cancer
por: Kikuchi, Ryota, et al.
Publicado: (2021)

Glasgow prognostic score for prediction of chemotherapy‐triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer
por: Kikuchi, Ryota, et al.
Publicado: (2021)

Glasgow Prognostic Score predicts chemotherapy‐triggered acute exacerbation‐interstitial lung disease in patients with non‐small cell lung cancer
por: Kikuchi, Ryota, et al.
Publicado: (2021)

Surfactant protein D: A useful biomarker for distinguishing COVID‐19 pneumonia from COVID‐19 pneumonia‐like diseases
por: Togashi, Yuki, et al.
Publicado: (2022)

Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID‐19
por: Ishiwari, Mayuko, et al.
Publicado: (2020)

Orbital apex syndrome associated with intraorbital metastasis of lung cancer
por: Ookuma, Takashi, et al.
Publicado: (2022)

Double‐ring sign in granulocyte colony‐stimulating factor‐induced vasculitis
por: Mizushima, Reimi, et al.
Publicado: (2022)

Chylothorax after spinal fusion surgery: A case report and literature review
por: Toriyama, Kazutoshi, et al.
Publicado: (2019)

A case of imatinib-related obstructive bronchiolitis followed long term
por: Yajima, Chika, et al.
Publicado: (2020)

Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations
por: Aoyama, Junichi, et al.
Publicado: (2019)

Favipiravir-induced fever in coronavirus disease 2019: A report of two cases
por: Takoi, Hiroyuki, et al.
Publicado: (2020)

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
por: Nishina, Naoshi, et al.
Publicado: (2020)

In vitro anticancer effect of azithromycin targeting hypoxic lung cancer cells via the inhibition of mitophagy
por: Toriyama, Kazutoshi, et al.
Publicado: (2023)

Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease
por: Kori, Mayuko, et al.
Publicado: (2020)

Clinical characteristics of anti‐MDA5 antibody‐positive interstitial lung disease
por: Kaenmuang, Punchalee, et al.
Publicado: (2020)

Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
por: Selva-O’Callaghan, A., et al.
Publicado: (2021)

Roles of biomarkers in anti‐MDA5‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
por: Li, Xiaomeng, et al.
Publicado: (2022)

Azithromycin enhances the cytotoxicity of DNA‐damaging drugs via lysosomal membrane permeabilization in lung cancer cells
por: Toriyama, Kazutoshi, et al.
Publicado: (2021)

Anti-MDA5 Antibody-positive Dermatomyositis with Rapidly Progressive Interstitial Pneumonia Presenting with Nephrotic Syndrome during Treatment with Corticosteroids and Cyclosporine
por: Kawamoto, Shinya, et al.
Publicado: (2021)

Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis
por: Fujita, Yuya, et al.
Publicado: (2018)

Oral mite anaphylaxis after ingestion of Korean pancake
por: Senba, Seitaro, et al.
Publicado: (2020)

Management of MDA-5 antibody-positive dermatomyositis with interstitial lung disease—an Auckland case series
por: Dick, Michael, et al.
Publicado: (2021)

Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
por: Tavakolian, Kameron, et al.
Publicado: (2022)

Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease
por: Chen, Xixia, et al.
Publicado: (2023)

Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports
por: Takahashi, Rina, et al.
Publicado: (2021)

Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
por: Ikeda, Satoshi, et al.
Publicado: (2015)

MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report
por: Alqatari, Safi, et al.
Publicado: (2018)

Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease
por: Intapiboon, Porntip, et al.
Publicado: (2020)

2. Two cases of anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease
por: Levasseur, Kirsty, et al.
Publicado: (2019)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
por: Aissaoui, Houari, et al.
Publicado: (2021)

Neurogenic pulmonary edema caused by right insular cortex infarction
por: Tanaka, Akane, et al.
Publicado: (2023)

Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
por: Li, Liubing, et al.
Publicado: (2017)

Anti-cancer strategy targeting the energy metabolism of tumor cells surviving a low-nutrient acidic microenvironment
por: Maeda, Yuki, et al.
Publicado: (2020)

Successful treatment of telomeropathy‐related interstitial lung disease with immunosuppression and danazol
por: Chambers, Daniel C., et al.
Publicado: (2020)

Immunosuppressive therapy before and during pregnancy may improve obstetric outcomes in pregnancy complicated by dermatomyositis with anti-MDA-5 antibody positivity: A case report
por: Goto, Hiroyuki, et al.
Publicado: (2023)

Risk factors for unsuccessful removal of central venous access ports implanted in the forearm of adult oncologic patients
por: Kinoshita, Mitsuhiro, et al.
Publicado: (2021)

Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases
por: Mehta, Asmita A, et al.
Publicado: (2021)

Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: The CRAFT Model
por: Guo, Jinqiang, et al.
Publicado: (2023)

Disseminated Bacillus Calmette–Guérin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review
por: Shimizu, Gen, et al.
Publicado: (2020)

A case report of revision occipital-cervical fusion after atlanto-axial instrumentation failure for neurofibromatosis type I
por: Kinoshita, Hayato, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qit0kaeum0eh6hnqidmfnmlv77